US Stock MarketDetailed Quotes

TVTX Travere Therapeutic

Watchlist
  • 14.010
  • -1.030-6.85%
Close Sep 27 16:00 ET
  • 14.700
  • +0.690+4.93%
Post 20:02 ET
1.07BMarket Cap-7826P/E (TTM)

Travere Therapeutic Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Travere Therapeutic Q2 2024 Earnings Date

Currency：USDAug 1, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
52.69M
54.12M
+1.43M
Beat Est.
-11.74%
+68.08%
+2.71%
EPS
-0.82
-0.91
-0.09
Miss Est.
+27.68%
+19.47%
-11.36%
Analyst Rating
Strong Buy

Sep 27, 2024

Travere Therapeutic Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 13 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 71.009M--
--2024/Q3-- / 62.226M--
Aug 1, 20242024/Q254.116M / 52.686M--
May 6, 20242024/Q141.374M / 43.616M--
Feb 15, 20242023/Q445.059M / 41.816M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 71.009M--
--2024/Q3-- / 62.226M--
Aug 1, 20242024/Q254.116M / 52.686M--
May 6, 20242024/Q141.374M / 43.616M--
Feb 15, 20242023/Q445.059M / 41.816M--

Unlock Free Earnings Estimates

Travere Therapeutic Earnings Reports

  • Travere Therapeutic | 10-Q: Q2 2024 Earnings Report

    Aug 1 16:42 ET

  • Travere Therapeutic | 10-Q: Q1 2024 Earnings Report

    May 6 16:51 ET

  • Travere Therapeutic | 10-K: FY2023 Annual Report

    Feb 20 08:13 ET

  • Travere Therapeutic | 10-Q: Q3 2023 Earnings Report

    Nov 7, 2023 17:14 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 27, 2024

    Strong Buy

    • Buy

      78.57%

    • Hold

      21.43%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data